2017 Haematology Abstracts

GCOS2017-P2-028

Prospective study of frequency and severity of cardiac events during proteasome inhibitor therapy for relapsed multiple myeloma

Presenting Author: Dr. Robert F. Cornell, Assistant Professor, Vanderbilt – Haematology, Nashville, TN, USA

 

GCOS2017-P2-029

Adverse cardiovascular risk profile in multiple myeloma patients undergoing autologous stem cell transplantation does not impact early mortality

Presenting Author: Willeke Naaktgeboren, Medical Student, Barts Health NHS Trust, West Smithfield, London, United Kingdom

 

GCOS2017-P2-030

Pre-existing coronary artery disease is associated with higher risk of cardiotoxicity in patients undergoing hematopoietic stem cell transplant

Presenting Author: Dr. Isaac Rhea, Cardiology Fellow, University Hospitals Cleveland Medical Centre, Cleveland, OH, USA

 

GCOS2017-P2-031

Risk of cardiotoxicity is higher in allogenic versis autologus stem cell transplantation

Presenting Author: Dr. Isaac Rhea, Cardiology Fellow, University Hospitals Cleveland Medical Centre, Cleveland, OH, USA

 

GCOS2017-P2-032

Cardioprotective therapy for prevention of cardiotoxicity in hematopoietic stem cell transplantation

Presenting Author: Dr. Isaac Rhea, Cardiology Fellow, University Hospitals Cleveland Medical Centre, Cleveland, OH, USA

 

GCOS2017-P2-033

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

Presenting Author: Dr. Sarah Shin, Resident, University at Buffalo Internal Medicine Residency, Amherst, USA